Table 5.
Vital sign changes between baseline and 8 weeks of test substance administration
| KRG group (n = 50) |
Placebo group (n = 50) |
p-value‡ |
|||||
|---|---|---|---|---|---|---|---|
| Mean ± SD | p-value∗ | Mean ± SD | p-value† | ||||
| Blood pressure (mmHg) | Systolic | W0 | 116.44 ± 10.70 | 119.32 ± 10.82 | 0.7679 | ||
| W8 | 116.33 ± 10.70 | 0.7733 | 118.36 ± 11.36 | 0.4944 | |||
| W8–W0 | −0.39 ± 9.37 | −0.96 ± 9.86 | |||||
| Diastolic | W0 | 72.74 ± 8.46 | 74.08 ± 8.06 | 0.1559 | |||
| W8 | 72.63 ± 9.76 | 1.0000 | 76.44 ± 9.03 | 0.0569 | |||
| W8–W0 | 0.00 ± 7.84 | 2.36 ± 8.56 | |||||
| Pulse (pulse/min) | W0 | 75.64 ± 10.61 | 76.52 ± 9.60 | 0.6861 | |||
| W8 | 74.69 ± 9.55 | 0.5767 | 74.64 ± 8.96 | 0.2497 | |||
| W8–W0 | −0.94 ± 11.69 | −1.88 ± 11.41 | |||||
| Body temperature (°C) | W0 | 36.62 ± 0.20 | 36.55 ± 0.21 | 0.5892 | |||
| W8 | 36.61 ± 0.23 | 0.8581 | 36.58 ± 0.25 | 0.5859 | |||
| W8–W0 | −0.01 ± 0.24 | 0.02 ± 0.31 | |||||
KRG, Korean Red Ginseng; SD, standard deviation; W8, 8th week; W0, Baseline.
∗
Analyzed by Paired t-test (compared within treatment group).
†
Analyzed by Paired t-test (compared within control group).
‡
Analyzed by Paired t-test (compared between groups: baseline–8th week).